Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve diseaseJens Fielitz, Vera Regitz‐Zagrosek, Jutta Schaper et al.|Journal of the American College of Cardiology|2001Cited by 160
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure†Erland Erdmann, Alexandre Mebazaa, Marc J. Semigran et al.|European Heart Journal|2012Cited by 155